Zhang, N., Zhang, C., Zeng, Z., Zhang, J., Du, S., Bao, C., & Wang, Z. (2021). Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis. J Inflamm Res.
Styl ChicagoZhang, Ning, Changqing Zhang, Zhihong Zeng, Jiyong Zhang, Shengnan Du, Chunde Bao, a Zhe Wang. "Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis." J Inflamm Res 2021.
Citace podle MLAZhang, Ning, et al. "Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis." J Inflamm Res 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..